29299155|t|Neuroprotection by aripiprazole against beta-amyloid-induced toxicity by P-CK2alpha activation via inhibition of GSK-3beta.
29299155|a|Psychosis is reported over 30% of patients with Alzheimer's disease (AD) in clinics. Aripiprazole is an atypical antipsychotic drug with partial agonist activity at the D2 dopamine and 5-HT1A receptors with low side-effect profile. We identified aripiprazole is able to overcome the amyloid-beta (Abeta)-evoked neurotoxicity and then increase the cell viability. This study elucidated the mechanism(s) by which aripiprazole ameliorates Abeta1-42-induced decreased neurite outgrowth and viability in neuronal cells. Pretreatment with aripiprazole increased Brain-derived neurotrophic factor (BDNF) mRNA and protein expressions in N2a cells. Additionally, phosphorylated casein kinase 2alpha at Y 255 (P-CK2alpha) was increased in time- and concentration-dependent manners. Furthermore, Abeta1-42-induced decreased BDNF and P-CK2alpha expression were increased over control level by aripiprazole. Subsequently, Abeta1-42-induced decreased levels of phosphorylated glycogen synthase-3beta at Ser9 (P-GSK-3beta) and nuclear P-beta-catenin (Ser675) were elevated by aripiprazole, which were inhibited by K252A (inhibitor of BDNF receptor) and tetrabromocinnamic acid (TBCA, CK2 inhibitor), indicating that BDNF and P-CK2alpha activation are implicated in the aripiprazole effects. Expressions of cyclin D1 and insulin-like growth factor 2 (IGF2) mRNA were increased by aripiprazole; even in the presence of Abeta1-42, which was blocked by K252A and TBCA. In CK2alpha gene-silenced N2a cells, aripiprazole failed to increase P-GSK-3beta and P-beta-catenin expressions. Consequently, aripiprazole ameliorated Abeta1-42-induced attenuation of neurite elongation in HT22 cells, and this effect was blocked by both TBCA and imatinib. Decreased viability induced by Abeta1-42 was recovered by aripiprazole. These findings provide evidence supporting that aripiprazole can provide an effective therapeutic strategy against Abeta-induced neurotoxicity in AD-associated psychosis.
29299155	19	31	aripiprazole	Chemical	MESH:D000068180
29299155	61	69	toxicity	Disease	MESH:D064420
29299155	113	122	GSK-3beta	Gene	56637
29299155	124	133	Psychosis	Disease	MESH:D011618
29299155	158	166	patients	Species	9606
29299155	172	191	Alzheimer's disease	Disease	MESH:D000544
29299155	193	195	AD	Disease	MESH:D000544
29299155	209	221	Aripiprazole	Chemical	MESH:D000068180
29299155	370	382	aripiprazole	Chemical	MESH:D000068180
29299155	407	419	amyloid-beta	Gene	351
29299155	421	426	Abeta	Gene	351
29299155	435	448	neurotoxicity	Disease	MESH:D020258
29299155	535	547	aripiprazole	Chemical	MESH:D000068180
29299155	657	669	aripiprazole	Chemical	MESH:D000068180
29299155	680	713	Brain-derived neurotrophic factor	Gene	12064
29299155	715	719	BDNF	Gene	12064
29299155	753	756	N2a	CellLine	CVCL:0470
29299155	937	941	BDNF	Gene	12064
29299155	1005	1017	aripiprazole	Chemical	MESH:D000068180
29299155	1121	1130	GSK-3beta	Gene	56637
29299155	1146	1158	beta-catenin	Gene	12387
29299155	1185	1197	aripiprazole	Chemical	MESH:D000068180
29299155	1223	1228	K252A	ProteinMutation	tmVar:p|SUB|K|252|A;HGVS:p.K252A;VariantGroup:0;OriginalGene:13000;CorrespondingGene:1459;CorrespondingSpecies:10090
29299155	1262	1285	tetrabromocinnamic acid	Chemical	MESH:C518786
29299155	1287	1291	TBCA	Chemical	MESH:C518786
29299155	1293	1296	CK2	Gene	13000
29299155	1325	1329	BDNF	Gene	12064
29299155	1378	1390	aripiprazole	Chemical	MESH:D000068180
29299155	1415	1424	cyclin D1	Gene	12443
29299155	1429	1457	insulin-like growth factor 2	Gene	16002
29299155	1459	1463	IGF2	Gene	16002
29299155	1488	1500	aripiprazole	Chemical	MESH:D000068180
29299155	1558	1563	K252A	ProteinMutation	tmVar:p|SUB|K|252|A;HGVS:p.K252A;VariantGroup:0;OriginalGene:13000;CorrespondingGene:1459;CorrespondingSpecies:10090
29299155	1568	1572	TBCA	Chemical	MESH:C518786
29299155	1600	1603	N2a	CellLine	CVCL:0470
29299155	1611	1623	aripiprazole	Chemical	MESH:D000068180
29299155	1645	1654	GSK-3beta	Gene	56637
29299155	1661	1673	beta-catenin	Gene	12387
29299155	1701	1713	aripiprazole	Chemical	MESH:D000068180
29299155	1781	1785	HT22	CellLine	CVCL:0321
29299155	1829	1833	TBCA	Chemical	MESH:C518786
29299155	1838	1846	imatinib	Chemical	MESH:D000068877
29299155	1906	1918	aripiprazole	Chemical	MESH:D000068180
29299155	1968	1980	aripiprazole	Chemical	MESH:D000068180
29299155	2035	2040	Abeta	Gene	11820
29299155	2049	2062	neurotoxicity	Disease	MESH:D020258
29299155	2066	2068	AD	Disease	MESH:D000544
29299155	2080	2089	psychosis	Disease	MESH:D011618
29299155	Association	MESH:D011618	11820
29299155	Negative_Correlation	MESH:D000068180	MESH:D020258
29299155	Association	MESH:D000068180	HGVS:p.K252A;CorrespondingGene:1459
29299155	Positive_Correlation	MESH:D020258	351
29299155	Positive_Correlation	MESH:D000068180	12064
29299155	Negative_Correlation	MESH:D000068180	351
29299155	Association	MESH:D000068180	13000
29299155	Positive_Correlation	MESH:D000068180	16002
29299155	Negative_Correlation	MESH:C518786	16002
29299155	Positive_Correlation	MESH:D020258	11820
29299155	Negative_Correlation	MESH:C518786	13000
29299155	Association	MESH:D000544	11820
29299155	Association	MESH:D000068180	MESH:D064420
29299155	Positive_Correlation	MESH:D000068180	12387
29299155	Negative_Correlation	MESH:C518786	MESH:D000068180
29299155	Negative_Correlation	MESH:C518786	12387
29299155	Negative_Correlation	MESH:C518786	12443
29299155	Positive_Correlation	MESH:D000068180	56637
29299155	Association	MESH:D000068180	11820
29299155	Positive_Correlation	MESH:D000068180	12443

